Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation: 21/04/2021, Revision: 14, Status: Authorised

Overview of comments received on Q&A regarding co-processed excipients used in solid oral dosage forms H and V (EMA/CHMP/CVMP/QWP/422493/2024)

ICH E20 adaptive designs for clinical trials - Scientific guideline

HMA-EMA joint Network Data Steering Group meeting - 13 January 2026

PDCO minutes of the 9-12 December 2025 meeting

Human medicines European public assessment report (EPAR): Yesintek, ustekinumab, Date of authorisation: 14/02/2025, Revision: 3, Status: Authorised

PSUSA/00002042/202507

Good pharmacovigilance practices (GVP)

Human medicines European public assessment report (EPAR): Hefiya, adalimumab, Date of authorisation: 26/07/2018, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Ibuprofen Gen.Orph, ibuprofen, Date of authorisation: 16/02/2024, Revision: 3, Status: Authorised